Work

Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression

Year: 2019

Type: article

Source: Journal of Affective Disorders

DOI: 10.1016/j.jad.2019.09.017

Authors: Naji C. Salloum, Maurizio Fava, Rebecca S. Hock, Marlene P. Freeman, Martina Flynn, Bettina Hoeppner, Cristina Cusin, Dan V. Iosifescu, Madhukar H. Trivedi, Gerard Sanacora, Sanjay J. Mathew, Charles Debattista, Dawn F. Ionescu, George I. Papakostas

Institutions: Harvard University, Massachusetts General Hospital, New York University, The University of Texas Southwestern Medical Center, Yale University, Michael E. DeBakey VA Medical Center, Baylor College of Medicine, Stanford Medicine, Stanford University

Language: English

Topic: Treatment of Major Depression

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute of Mental Health, National Institute on Drug Abuse, National Center for Advancing Translational Sciences

Awards: Neurobiological Underpinnings of Placebo Response in Depression, G2169753111, G2908742357, G8248535489, Yale Clinical and Translational Science Award

OpenAlex ID: W2971894339

FWCI: 2.79

Cites: 26

Cited by: 34

Related to: 10